In conclusion, we suggest that sarcoidosis patients should be closely monitored for: (a) the presence of antiphospholipid antibody positivity; (b) any previous venous thromboembolism episodes; and (c) a reduced CD4 and CD8 lymphocyte ratio. This evidence concerns the gene CD4 and sarcoidosis.